The average one-year price target for GoodRx Holdings (NasdaqGS:GDRX) has been revised to $2.87 / share. This is a decrease ...

GoodRx Holdings Inc. (NASDAQ:GDRX), a leading healthcare technology company specializing in prescription drug discounts and telehealth services, finds itself at a critical juncture. As the company ...

GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of Ozempic (semaglutide) and Wegovy (semaglutide) pens are available to eligible ...

GoodRx Holdings Inc (NASDAQ:GDRX) shares are pulling back Tuesday morning, as investors potentially take profits following Monday’s surge. The stock had jumped over 30% Monday after the company ...

Across the recent three months, 4 analysts have shared their insights on GoodRx Holdings (NASDAQ:GDRX), expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...

Leerink Partners analyst Michael Cherny has reiterated their bullish stance on GDRX stock, giving a Buy rating on November 13. Don't Miss our Black Friday Offers: Unlock your investing potential with ...

Shareholders of Santa Monica-based GoodRx Holdings Inc. have undergone a considerable amount of pain as the digital health ...